According to the immune factor analysis, the low-risk group had higher immune cell infiltration, including CD8+ T cells, MDSCs, type 2 T helper cells, and other tumor-killing immune cells, whereas the high-risk group had an immunosuppressive TME. This evidence concerns the gene CD8A and neoplasm.